Each Pfs/ Amp/Vial Contains Ranibizumab Upto2.3 Mg/0.23Ml (The Drug Should Be Dgci Approved For Diabetic Macular Oedema, Retinal Vein Occlusion, Proliferative Diabetic Retinopathy, Reti Nopathy Of Prematurity And Myopic Choroidal Neovascular Membrane) ]